In the shadow of the U.S. FDA revoking its approval of Avastin for the treatment of metastatic breast cancer, the Canadian counterpart agency is following suit. According to the Toronto Sun: The agency said Avastin “has not been shown to be safe and effective” ………..Based on follow-up studies after Avastin was first authorized in Feb. [...]
Read More...











